Fisher & Paykel Healthcare (ASX:FPH) Addresses Impact of New US Tariffs
Fisher & Paykel Healthcare (ASX:FPH) outlines its response to new US tariffs, detailing operational and financial strategies.
Fisher & Paykel Healthcare (ASX:FPH) outlines its response to new US tariffs, detailing operational and financial strategies.
Cochlear Limited (ASX:COH) awaits clarification on new US export tariffs, expecting further details and market updates soon.
Atomos Limited (ASX:AMS) secures a $13.7m debt facility to achieve cashflow positivity by FY26, avoiding equity dilution.
RPMGlobal Holdings Limited (ASX:RUL) completes divestment of its Advisory division and plans for potential capital return to shareholders.
The Star Entertainment Group Limited (ASX:SGR) withdraws its refinancing proposal, highlighting ongoing liquidity challenges and uncertainty about its future operations.
Mesoblast (ASX:MSB) enters Medicaid agreement with CMS for Ryoncil®, enabling treatment for children with SR-aGvHD.
Orora Limited (ASX:ORA) announces a review by the French Competition Authority on practices related to its Saverglass acquisition.
Artrya Limited (ASX:AYA) secures FDA clearance for Salix® Coronary Anatomy, facilitating its commercial launch in the US market.
The Star Entertainment Group (ASX:SGR) confirms Sydney casino licence suspension extended until September 2025 amid ongoing remediation efforts.
Inca Minerals Limited (ASX:ICG) halts trading pending a proposed capital raising announcement.